The role of cardiovascular magnetic resonance in sudden death risk stratification in hypertrophic cardiomyopathy
- PMID: 26002385
- DOI: 10.1016/j.ccep.2015.03.003
The role of cardiovascular magnetic resonance in sudden death risk stratification in hypertrophic cardiomyopathy
Abstract
Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in young patients, but current risk stratification strategies do not identify all patients at risk. Contrast-enhanced cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) can identify areas of abnormal myocardial substrate comprising fibrosis, the structural nidus for potentially life-threatening ventricular arrhythmias. More recently, follow-up studies have demonstrated a strong relationship between extent of LGE in patients with HCM and increased risk of adverse disease-related events, including sudden death.
Keywords: Cardiovascular magnetic resonance; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Myocardial fibrosis; Sudden death.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094. Circulation. 2014. PMID: 25092278 Clinical Trial.
-
Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.J Card Fail. 2008 Jun;14(5):414-9. doi: 10.1016/j.cardfail.2008.02.006. Epub 2008 May 27. J Card Fail. 2008. PMID: 18514934
-
Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.Cardiol J. 2014;21(1):29-32. doi: 10.5603/CJ.a2013.0115. Epub 2013 Aug 30. Cardiol J. 2014. PMID: 23990187
-
Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.Cardiol J. 2016;23(3):250-63. doi: 10.5603/CJ.a2016.0019. Epub 2016 Apr 11. Cardiol J. 2016. PMID: 27064795 Review.
-
Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):518-25. doi: 10.1093/ehjci/jes302. Epub 2013 Jan 16. Eur Heart J Cardiovasc Imaging. 2013. PMID: 23324829 Review.
Cited by
-
Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy.Am Heart J. 2023 Oct;264:153-162. doi: 10.1016/j.ahj.2023.06.005. Epub 2023 Jun 12. Am Heart J. 2023. PMID: 37315879 Free PMC article.
-
Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist?World J Cardiol. 2017 Oct 26;9(10):773-786. doi: 10.4330/wjc.v9.i10.773. World J Cardiol. 2017. PMID: 29104737 Free PMC article. Review.
-
Usefulness of TI-scout images in the assessment of late gadolinium enhancement in children.J Cardiovasc Magn Reson. 2021 Mar 18;23(1):28. doi: 10.1186/s12968-021-00719-2. J Cardiovasc Magn Reson. 2021. PMID: 33731161 Free PMC article.
-
Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.Neth Heart J. 2017 Mar;25(3):186-199. doi: 10.1007/s12471-016-0943-2. Neth Heart J. 2017. PMID: 28005231 Free PMC article.
-
Small Vessel Disease: Another Component of the Hypertrophic Cardiomyopathy Phenotype Not Necessarily Associated with Fibrosis.J Clin Med. 2021 Feb 4;10(4):575. doi: 10.3390/jcm10040575. J Clin Med. 2021. PMID: 33557065 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources